Maxifed is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Mcr American Pharmaceuticals, Inc.. The primary component is Guaifenesin; Pseudoephedrine Hydrochloride.
| Product ID | 58605-101_f954e296-1429-4985-9d04-a20b67e2cf71 | 
| NDC | 58605-101 | 
| Product Type | Human Otc Drug | 
| Proprietary Name | Maxifed | 
| Generic Name | Guaifenesin And Pseudoephedrine Hydrochloride | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2018-04-01 | 
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL | 
| Application Number | part341 | 
| Labeler Name | MCR American Pharmaceuticals, Inc. | 
| Substance Name | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE | 
| Active Ingredient Strength | 360 mg/1; mg/1 | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2018-04-01 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | OTC monograph final | 
| Application Number | part341 | 
| Product Type | HUMAN OTC DRUG | 
| Marketing Start Date | 2018-04-01 | 
| Marketing Category | OTC monograph final | 
| Application Number | part341 | 
| Product Type | HUMAN OTC DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2018-04-01 | 
| Ingredient | Strength | 
|---|---|
| GUAIFENESIN | 360 mg/1 | 
| SPL SET ID: | 8a1be614-2a78-4899-9697-774479f2daa5 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 58605-101 | Maxifed | GUAIFENESIN and Pseudoephedrine Hydrochloride | 
| 66992-281 | Entex T | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 79903-125 | equate mucus d | guaifenesin and pseudoephedrine hydrochloride | 
| 0363-0077 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 41415-994 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 51660-071 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 62011-0475 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 0363-9930 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 0536-1333 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 51316-993 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 70000-0580 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 51316-970 | MAXIMUM STRENGTH Mucus D | guaifenesin and pseudoephedrine hydrochloride | 
| 50090-1075 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 50090-1076 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 63824-041 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 63824-057 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 68258-3035 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 70518-0523 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride | 
| 0536-1137 | Mucus Relief D | Guaifenesin and Pseudoephedrine Hydrochloride | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() MAXIFED  75130397  2242345 Live/Registered  | 
        MCR American Pharmaceuticals, Inc.  1996-07-05  | 
![]() MAXIFED  74546782  not registered Dead/Abandoned  | 
        JOHNSON & JOHNSON  1994-07-07  | 
![]() MAXIFED  74026406  not registered Dead/Abandoned  | 
        Johnson & Johnson  1990-02-06  |